Márta Zarándi

2.3k total citations
67 papers, 2.0k citations indexed

About

Márta Zarándi is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Márta Zarándi has authored 67 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in Márta Zarándi's work include Growth Hormone and Insulin-like Growth Factors (41 papers), Cancer-related Molecular Pathways (15 papers) and Alzheimer's disease research and treatments (14 papers). Márta Zarándi is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (41 papers), Cancer-related Molecular Pathways (15 papers) and Alzheimer's disease research and treatments (14 papers). Márta Zarándi collaborates with scholars based in United States, Hungary and Germany. Márta Zarándi's co-authors include Andrew V. Schally, Botond Penke, József L. Varga, Gábor Halmos, Yann Verdier, Ferenc G. Rick, Kate Groot, Norman L. Block, Luca Szalontay and Irving Vidaurre and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

Márta Zarándi

67 papers receiving 1.9k citations

Peers

Márta Zarándi
Renhui Yang United States
Shao-Hua Yang United States
Aqeela Afzal United States
Woo Jean Kim South Korea
Xiangdong Xu China
Angelino Calderone Canada
Kaoru Tateno Japan
J. Wayne Leitner United States
Elena Rapizzi Italy
Michel Pierre France
Renhui Yang United States
Márta Zarándi
Citations per year, relative to Márta Zarándi Márta Zarándi (= 1×) peers Renhui Yang

Countries citing papers authored by Márta Zarándi

Since Specialization
Citations

This map shows the geographic impact of Márta Zarándi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Márta Zarándi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Márta Zarándi more than expected).

Fields of papers citing papers by Márta Zarándi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Márta Zarándi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Márta Zarándi. The network helps show where Márta Zarándi may publish in the future.

Co-authorship network of co-authors of Márta Zarándi

This figure shows the co-authorship network connecting the top 25 collaborators of Márta Zarándi. A scholar is included among the top collaborators of Márta Zarándi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Márta Zarándi. Márta Zarándi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zarándi, Márta, Renzhi Cai, Magdolna Kovács, et al.. (2017). Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth. Peptides. 89. 60–70. 52 indexed citations
2.
Szalontay, Luca, Ronald J. Benveniste, Andrew V. Schally, et al.. (2012). Inhibitory Effects of GHRH Antagonists on Human GH-Secreting Adenoma Tissue. Neuroendocrinology. 96(1). 81–88. 5 indexed citations
3.
Klukovits, Anna, Andrew V. Schally, Luca Szalontay, et al.. (2011). Novel antagonists of growth hormone‐releasing hormone inhibit growth and vascularization of human experimental ovarian cancers. Cancer. 118(3). 670–680. 30 indexed citations
4.
5.
6.
Pozsgai, Éva, Andrew V. Schally, Márta Zarándi, et al.. (2010). The effect of GHRH antagonists on human glioblastomas and their mechanism of action. International Journal of Cancer. 127(10). 2313–2322. 16 indexed citations
7.
Kovács, Magdolna, Andrew V. Schally, Florian Hohla, et al.. (2010). A correlation of endocrine and anticancer effects of some antagonists of GHRH. Peptides. 31(10). 1839–1846. 22 indexed citations
8.
Hohla, Florian, Stefan Buchholz, Andrew V. Schally, et al.. (2009). GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells. Cell Cycle. 8(19). 3149–3156. 35 indexed citations
9.
Laczkó, Ilona, Elemér Vass, Katalin Soós, et al.. (2008). Aggregation of Aβ(1–42) in the presence of short peptides: conformational studies. Journal of Peptide Science. 14(6). 731–741. 15 indexed citations
10.
Kanashiro, Célia A., et al.. (2007). Alterations of EGFR/HER, angiogenesis and apoptosis pathways after therapy with antagonists of growth hormone releasing hormone and bombesin in non-small cell lung cancer. International Journal of Oncology. 30(4). 1019–28. 29 indexed citations
11.
Zarándi, Márta, Katalin Soós, Lívia Fülöp, et al.. (2006). Synthesis of Aβ[1‐42] and its derivatives with improved efficiency. Journal of Peptide Science. 13(2). 94–99. 43 indexed citations
12.
Stangelberger, Anton, Andrew V. Schally, József L. Varga, et al.. (2005). Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling. European Journal of Cancer. 41(17). 2735–2744. 30 indexed citations
13.
Verdier, Yann, Márta Zarándi, & Botond Penke. (2004). Amyloid β‐peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. Journal of Peptide Science. 10(5). 229–248. 213 indexed citations
14.
15.
Hetényi, Csaba, Zoltán Szabó, Éva Klement, et al.. (2002). Pentapeptide Amides Interfere with the Aggregation of β-Amyloid Peptide of Alzheimer's Disease. Biochemical and Biophysical Research Communications. 292(4). 931–936. 57 indexed citations
16.
Fülöp, Lívia, Botond Penke, & Márta Zarándi. (2001). Synthesis and fluorescent labeling of beta‐amyloid peptides. Journal of Peptide Science. 7(8). 397–401. 25 indexed citations
17.
Harkany, Tibor, Jan N. Keijser, John Kelly, et al.. (2001). β-Amyloid(1-42)-Induced Cholinergic Lesions in Rat Nucleus Basalis Bidirectionally Modulate Serotonergic Innervation of the Basal Forebrain and Cerebral Cortex. Neurobiology of Disease. 8(4). 667–678. 41 indexed citations
18.
Pákáski, Magdolna, Zoltán Farkas, P. Kása, et al.. (1998). Vulnerability of small GABAergic neurons to human β-amyloid pentapeptide. Brain Research. 796(1-2). 239–246. 23 indexed citations
19.
Laskay, G., et al.. (1997). A Putative Tetrapeptide Antagonist Prevents β-Amyloid-Induced Long-Term Elevation of [Ca2+]iin Rat Astrocytes. Biochemical and Biophysical Research Communications. 235(3). 479–481. 24 indexed citations
20.
Zarándi, Márta, Péter Serfózó, L. Bokser, et al.. (1992). Potent agonists of growth hormone‐releasing hormone. International journal of peptide & protein research. 39(3). 211–217. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renhui Yang Breakdown of academic impact, for papers by Shao-Hua Yang Breakdown of academic impact, for papers by Aqeela Afzal Breakdown of academic impact, for papers by Woo Jean Kim Breakdown of academic impact, for papers by Xiangdong Xu Breakdown of academic impact, for papers by Angelino Calderone Breakdown of academic impact, for papers by Kaoru Tateno Breakdown of academic impact, for papers by J. Wayne Leitner Breakdown of academic impact, for papers by Elena Rapizzi Breakdown of academic impact, for papers by Michel Pierre
Rankless by CCL
2026